Rabbit Recombinant Monoclonal NCAP antibody. Suitable for I-ELISA, WB, IHC-P, ICC/IF, IP and reacts with Recombinant fragment - Influenza B, Transfected cell lysate - Influenza B, Transfected cell line - Influenza B samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
I-ELISA | WB | IHC-P | ICC/IF | IP | Flow Cyt (Intra) | |
---|---|---|---|---|---|---|
Influenza B | Predicted | Predicted | Predicted | Predicted | Predicted | Not recommended |
Recombinant fragment - Influenza B | Tested | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Transfected cell line - Influenza B | Not recommended | Not recommended | Tested | Tested | Not recommended | Not recommended |
Transfected cell lysate - Influenza B | Not recommended | Tested | Not recommended | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Influenza B | Dilution info 1000 ng/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Influenza B, Transfected cell line - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Influenza B | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Influenza B, Transfected cell line - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell line - Influenza B | Dilution info 1/2000 | Notes Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Influenza B, Transfected cell lysate - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell line - Influenza B | Dilution info 1/50 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Influenza B, Transfected cell lysate - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Influenza B | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant fragment - Influenza B, Transfected cell line - Influenza B | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Influenza B, Recombinant fragment - Influenza B, Transfected cell lysate - Influenza B, Transfected cell line - Influenza B | Dilution info - | Notes - |
Select an associated product type
Encapsidates the negative strand viral RNA, protecting it from nucleases. The encapsidated genomic RNA is termed the ribonucleoprotein (RNP) and serves as template for transcription and replication. The RNP needs to be localized in the host nucleus to start an infectious cycle, but is too large to diffuse through the nuclear pore complex. NP comprises at least 2 nuclear localization signals that are responsible for the active RNP import into the nucleus through cellular importin alpha/beta pathway. Later in the infection, nclear export of RNPs are mediated through viral proteins NEP interacting with M1 which binds nucleoproteins. It is possible that nucleoprotein binds directly host exportin-1/XPO1 and plays an active role in RNPs nuclear export. M1 interaction with RNP seems to hide nucleoprotein's nuclear localization signals. Soon after a virion infects a new cell, M1 dissociates from the RNP under acidification of the virion driven by M2 protein. Dissociation of M1 from RNP unmasks nucleoprotein's nuclear localization signals, targeting the RNP to the nucleus.
Nucleoprotein, Nucleocapsid protein, Protein N, NP
Rabbit Recombinant Monoclonal NCAP antibody. Suitable for I-ELISA, WB, IHC-P, ICC/IF, IP and reacts with Recombinant fragment - Influenza B, Transfected cell lysate - Influenza B, Transfected cell line - Influenza B samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
The Influenza B Virus Nucleoprotein often known as NP or flu B NP is an essential structural protein with a molecular weight of approximately 56 kDa. It plays a role in the influenza B virus lifecycle by encapsidating the viral RNA forming the ribonucleoprotein complex important for viral replication and transcription. This protein expresses in the host cell's cytoplasm and nucleus facilitating the export of vRNPs from the nucleus.
The ribonucleoprotein complex formation involves nucleoproteins assembling with the viral RNA and polymerase subunits securing the genome for replication and transcription. NP interacts with both the polymerase basic 2 (PB2) and polymerase acidic (PA) proteins forming a vital part of the complex. This interaction allows the viral RNA to maintain its structure and function effectively during the virus infection cycle aiding both Influenza A and B viruses.
NP participates in the viral replication pathway supporting the influenza virus propagation in infected cells. It associates closely with viral RNA polymerases and is integral to the transcription and replication of the viral RNA genome. Other key proteins involved in these pathways include the polymerase basic 1 (PB1) protein essential for synthesizing viral mRNA and the matrix protein (M1) which aids in vRNA encapsidation and budding.
NP relates closely to influenza B infections contributing to the clinical symptoms of flu B such as fever and respiratory issues. This protein is also a potential target for vaccine and therapeutic development against influenza B. NP shares a connection with the M2 protein another target in antiviral strategies given its role in proton channel activity and viral uncoating. Understanding NP's role can guide the creation of flu B antibodies and influenza A and B antibodies to reduce disease severity or prevent flu infections.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Influenza B virus Nucleoprotein was immunoprecipitated from 0.35 mg 293T (human embryonic kidney epithelial cell) cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate with ab313885 at 1/30 dilution (2µg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab313885 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: 293T (human embryonic kidney epithelial cell) cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate
Lane 2: abab313885 IP in 293T (human embryonic kidney epithelial cell) cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate
Lane 3:Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab313885 in 293T cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST. Exposure time: 180 seconds
All lanes: Immunoprecipitation - Anti-Influenza B virus Nucleoprotein antibody [EPR28205-27] (ab313885) at 1/30 dilution
All lanes: 293T (human embryonic kidney epithelial cell) cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/5000 dilution
Exposure time: 180s
Blocking and diluting buffer and concentration: 5% NFDM/TBST
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (Anti-6X His tag® antibody [EPR20547] - ChIP Grade ab213204) staining at 1/5000 dilution
Exposure time: 26 seconds
All lanes: Western blot - Anti-Influenza B virus Nucleoprotein antibody [EPR28205-27] (ab313885) at 1/1000 dilution
Lane 1: 293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a myc-His-tag® whole cell lysate at 5 µg
Lane 2: 293T cells transfected with an Influenza B virus NP gene expression vector containing a myc-His-tag® whole cell lysate at 5 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 62 kDa, 65 kDa
Exposure time: 26s
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized 293T (Human embryonic kidney epithelial cell) transfected with an Influenza B virus NP gene expression vector containing a myc tag cells labelling Influenza B virus Nucleoprotein with ab313885 at 1/50 (10.16 µg/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 µg/ml) dilution (Green). Confocal image showing nuclear staining in 293T cells transfected with an Influenza B virus NP gene expression vector containing a myc tag. Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8) Myc-Tag Mouse mAb (Alexa Fluor® 647) was used to counterstain at 1/100 (0.38 µg/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 µg/ml) dilution.
Indirect ELISA analysis of abab313885 at 1000-0 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1:2500 dilution. Antigen: Influenza B virus Nucleoprotein. Antigen concentration: 1000 ng/ml
Immunohistochemical analysis of paraffin-embedded Human kidney tissue labeling Influenza B virus Nucleoprotein with ab313885 at 1/2000 (0.254 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Negative control: No staining on human kidney. The section was incubated with ab313885 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Immunohistochemical analysis of paraffin-embedded 293T (human tissue labeling Influenza B virus Nucleoprotein with ab313885 at 1/2000 (0.254 µg/ml) followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Nuclear staining on (A) 293T transfected with an Influenza B virus NP expression vector and no staining on (B) 293T transfected with empty vector. The section was incubated with ab313885 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection).Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com